Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
btx-a51 | cyclin-dependent kinase 7 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
btx-a51 | cyclin-dependent kinase 9 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
click here to return to the previous page |